Skip to main content

Table 5 Multivariate survival model analysis based on TIMER online tool

From: High CENPM mRNA expression and its prognostic significance in hepatocellular carcinoma: a study based on data mining

Clinicopathologic variable Coef HR (95% CI) P-value Sig
Age 0.012 1.01 (1.00–1.03) 0.177  
Gender Male − 0.071 0.93 (0.58–1.50) 0.769  
Race Black 1.185 3.27 (1.18–9.04) 0.022 *
Race White − 0.032 0.97 (0.58–1.61) 0.902  
Stage II 0.174 1.19 (0.70–2.02) 0.522  
Stage III 0.711 2.04 (1.24–3.33) 0.005 **
Stage IV 1.434 4.19 (1.20–14.60) 0.024 *
Purity 0.561 1.75 (0.55–5.58) 0.343  
B cells − 8.059 0.00 (0.00–0.59) 0.036 *
CD+ 8  cell − 5.678 0.003 (0.00–0.50) 0.026 *
CD4+ T cells − 6.886 0.001 (0.00–1.69) 0.069 ·
Macrophages 8.002 2987.33 (11.72–761,175.73) 0.005 **
Neutrphils − 1.906 0.15 (0.00–14,422.16) 0.745  
Dendritic 5.098 163.78 (3.78–7097.75) 0.008 **
CENPM 0.180 1.20 (1.04–1.38) 0.012 *
  1. P-value significant codes: 0 ≤ *** < 0.001 ≤ ** < 0.01 ≤ * < 0.05 ≤ · < 0.1